Safety and efficacy of glecaprevir/pibrentasvir in patients with chronic hepatitis C genotypes 1-6 receiving opioid substitution therapy

Jason Grebely (Lead / Corresponding author), Gregory J. Dore, Negar N. Alami, Brian Conway, John F. Dillon, Michael Gschwantler, Franco Felizarta, Christophe Hézode, Krzysztof Tomasiewicz, Linda M. Fredrick, Emily O. Dumas, Federico J. Mensa

Research output: Contribution to journalArticlepeer-review

19 Citations (Scopus)
149 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Safety and efficacy of glecaprevir/pibrentasvir in patients with chronic hepatitis C genotypes 1-6 receiving opioid substitution therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences

Social Sciences